If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Verona Pharma is looking odds on for a regulatory approval for its chronic obstructive pulmonary disease (COPD) therapy ensifentrine ... activity will step up quickly now that the combined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback